We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

RxSight Inc (RXST) USD0.001

Sell:$51.00 Buy:$51.17 Change: $0.48 (0.95%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$51.00
Buy:$51.17
Change: $0.48 (0.95%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$51.00
Buy:$51.17
Change: $0.48 (0.95%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

RxSight, Inc. is a commercial-stage medical technology company, which is engaged in improving the vision of patients following cataract surgery. The Company’s RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system includes the RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and various accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. It designed its RxSight system to address the shortcomings of competitive IOL technologies and provide a solution that doctors can trust to improve visual outcomes. Its RxSight system helps the surgeon perform a standard cataract procedure to implant the LAL and then uses the LDD to modify the lens with the visual correction needed for the patient’s vision outcomes.

Contact details

Address:
100 COLUMBIA STREET, SUITE 120
ALISO VIEJO
92656
United States
Telephone:
+1 (949) 5217822
Website:
https://www.rxsight.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
RXST
ISIN:
US78349D1072
Market cap:
$1.82 billion
Shares in issue:
36.99 million
Sector:
Health Care Supplies
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Ron Kurtz
    President, Chief Executive Officer, Director
  • Shelley Thunen
    Chief Financial Officer
  • Ilya Goldshleger
    Chief Operating Officer
  • Eric Weinberg
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.